Brief: Bellerophon Therapeutics Inc Got Notice Of Delisting From Nasdaq
24/07/2023 22:11
July 24 (Reuters) - Bellerophon Therapeutics Inc
BLPH.O :
* BELLEROPHON THERAPEUTICS INC - ON JULY 19, CO GOT NOTICE
OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
* BELLEROPHON THERAPEUTICS INC - PLANS TO TIMELY REQUEST A
HEARING
BEFORE NASDAQ PANEL
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen